Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
AstraZeneca
Genmab
STORM Therapeutics LTD
Tubulis GmbH
Eli Lilly and Company
Neonc Technologies, Inc.
Ipsen
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Merus B.V.
Aulos Bioscience, Inc.
Exscientia AI Limited
Amgen
One-carbon Therapeutics AB
Radiopharm Theranostics, Ltd
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Kura Oncology, Inc.
VM Oncology, LLC
Tanabe Pharma America, Inc.
Takeda
DualityBio Inc.
BicycleTx Limited
Volastra Therapeutics, Inc.
Dragonfly Therapeutics
Immunitas Therapeutics
BeiGene
Sichuan Baili Pharmaceutical Co., Ltd.
LigaChem Biosciences, Inc.
Scancell Ltd
Hoffmann-La Roche
GI Innovation, Inc.
A2 Biotherapeutics Inc.
Incyte Corporation
Yuhan Corporation
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
invoX Pharma Limited
Hummingbird Bioscience
Rakuten Medical, Inc.
Formation Biologics
Nektar Therapeutics
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
Klus Pharma Inc.
Rapa Therapeutics LLC
Precision Biologics, Inc
TiumBio Co., Ltd.
GeoVax, Inc.